| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/05/2007 | US20070078079 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity |
| 04/05/2007 | US20070077651 Cell culture vessel having a polymer surface, a cell adhesion resistant material (CAR) bonded to the polymer (e.g., hyaluronic acid), and one or more peptides covalently bound to the CAR material that promote adherence of cells that do not adhere to the CAR layer in the absence of the peptides |
| 04/05/2007 | US20070077195 "N and/or nalpha derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3 (co)3]+ by fac coordination" |
| 04/05/2007 | CA2623652A1 Antibody-drug conjugates and methods of use |
| 04/04/2007 | EP1573323A4 Prion protein ligands and methods of use |
| 04/04/2007 | EP1427405B1 Inflammation-inhibiting compounds |
| 04/04/2007 | CN1308347C Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 04/03/2007 | US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents |
| 04/03/2007 | US7199099 Treating grampositive bacterial infections |
| 04/03/2007 | US7198914 Comprises nucleotide sequences coding g protein coupled receptor for identifying modulator for treatment and prevention of cardiovascular, respiratory, muscle, liver, gastrointestinal, urogenital and blood disorders |
| 04/03/2007 | CA2165780C Selectively cleavable linkers based on iminodiacetic acid ester bonds |
| 03/29/2007 | WO2007012849A3 MASS LABELS FOR BIOMOLECULES CONTAINING A 2,6-DIMETHYL-PIPERIDIN-l-YL METHYLENE OR A PYRIMIDIN-2-YL THIOMETHYLENE MASS MARKER MOIETY AND A SUCCINIMID-OXY-CARBONYL REACTIVE FUNCTIONAL GROUP |
| 03/29/2007 | WO2005120558A3 Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease |
| 03/29/2007 | WO2004081197A3 Immune response associated proteins |
| 03/29/2007 | US20070073039 Peptides that inhibit viral infections |
| 03/29/2007 | US20070072935 Catalytic antioxidants and methods of use |
| 03/29/2007 | US20070072919 Preparing perindopril by reacting 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanine and octahydro 1H-indole-2-carboxylic acid or its ester with a uronium salt (O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate) in the presence of a tertiary amine in an aprotic solvent |
| 03/29/2007 | US20070072855 5-(5-Chloro-2,4-dihydroxy-phenyl)-4-(4-methoxy-phenyl)-2H-pyrazole-3-carboxylic acid, for example; for treatment of diseases which are mediated by excessive or inappropriate HSP90 activity, such as cancers |
| 03/29/2007 | US20070072809 Antiviral compounds |
| 03/29/2007 | US20070072808 Antimicrobial and anticancer lipopeptides |
| 03/29/2007 | US20070072792 Macrocyclic lactams and pharmaceutical use thereof |
| 03/28/2007 | EP1765863A1 Peptide-based compounds |
| 03/28/2007 | EP1765850A1 Substituted propane phosphinic acid derivatives |
| 03/28/2007 | EP1765375A1 Method for inhibiting angiogenesis and/or lymphangiogenesis |
| 03/28/2007 | EP1554305B1 Prion protein-binding peptide sequences |
| 03/28/2007 | EP1474441B1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c) |
| 03/28/2007 | CN1938425A Process for producing dipeptides |
| 03/28/2007 | CN1938332A Inhibitors of serine proteases, particularly HCV NS3-HS4A protease |
| 03/28/2007 | CN1938311A Macrocyclic compounds as inhibitors of viral replication |
| 03/28/2007 | CN1935834A Method for preparing tyr-silk-valine tripeptide |
| 03/28/2007 | CN1935833A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 03/27/2007 | US7196167 Identification and isolation of novel DNA and recombinant production of novel polypeptides |
| 03/27/2007 | US7196166 PRO polypeptides; fused to heterologous polypeptide sequences |
| 03/27/2007 | US7196163 Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
| 03/27/2007 | US7196099 Compounds and compositions as cathepsin inhibitors |
| 03/27/2007 | US7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 03/22/2007 | WO2007032887A2 Thio-containing inhibitors of aminopeptidase p, compositions thereof and method of use |
| 03/22/2007 | WO2007031698A1 Asymmetric synthesis of peptides |
| 03/22/2007 | WO2007031343A1 2-(AMINOMETHYL)-5-CHLOROBENZYLAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE CLOTTING FACTOR Xa |
| 03/22/2007 | WO2007006548A3 Antibacterial amide macrocycles vii |
| 03/22/2007 | WO2006126087A3 Angiotensin i-converting enzyme (ace) inhibitors |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis |
| 03/22/2007 | US20070066539 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
| 03/22/2007 | US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/22/2007 | CA2622173A1 Asymmetric synthesis of peptides |
| 03/22/2007 | CA2621549A1 2-(aminomethyl)-5-chlorobenzylamide derivatives and their use as inhibitors of the clotting factor xa |
| 03/21/2007 | EP1763531A1 Hepatitis c inhibitor peptide analogs |
| 03/21/2007 | EP1365787B1 Use of amino acid anticonvulsants for treatment of pain |
| 03/21/2007 | EP1237878B1 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 03/21/2007 | EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/21/2007 | EP0865446B1 Agents for promoting bone formation |
| 03/21/2007 | CN1934276A Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents |
| 03/21/2007 | CN1934130A Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections |
| 03/21/2007 | CN1934123A Intracellular delivery of osteoinductive proteins and peptides |
| 03/21/2007 | CN1934080A Amino acid and peptide conjugates of arylalkylic acids for cosmetic use |
| 03/21/2007 | CN1933847A SMAC peptidomimetics and the uses thereof |
| 03/21/2007 | CN1931873A Prepn process of L-alanyl-L-glutamine |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/20/2007 | US7193103 Reacting an admixture of N-(3,3-dimethylbutyl)-L-aspartic acid and a ketone or an acetal of a ketone in a first solvent for a time and at a temperature sufficient to produce an oxazolidinone derivative, reacting with L-phenylalanine or L-phenylalanine methyl ester in a second solvent |
| 03/20/2007 | US7193047 Identification and isolation of novel DNA and recombinant production of novel polypeptides |
| 03/20/2007 | US7193046 Polypeptide encoded by a nucleic acid overexpressed in esophageal and lung tumor, and underexpressesd in kidney tumor and melanoma |
| 03/20/2007 | US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents |
| 03/20/2007 | US7192957 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS |
| 03/20/2007 | US7192947 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 03/20/2007 | US7192945 Benzothiazepine derivatives |
| 03/20/2007 | US7192742 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages |
| 03/15/2007 | WO2007030804A1 Prion-specific peptoid reagents |
| 03/15/2007 | WO2007030656A1 Ring-closing metathesis process for the preparation of macrocyclic peptides |
| 03/15/2007 | WO2006132925A3 Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy |
| 03/15/2007 | WO2005007831A3 Compositions of protein mimetics and methods of using same against hiv-1, sars-cov and the like |
| 03/15/2007 | US20070060527 Orally administered small peptides synergize statin activity |
| 03/15/2007 | US20070060525 Thio-containing inhibitors of aminopeptidase P, compositions thereof and method of use |
| 03/15/2007 | US20070060510 for complex formation of hepatitis C non-structural protein-3 (NS3) with NS4A; enhancing the proteolytic efficacy at all of the sites; prevent reproduction of hepatitis virus |
| 03/15/2007 | US20070060502 Substituted propane phosphinic acid derivatives |
| 03/15/2007 | US20070059796 Binding motif and methods of regulating cell function |
| 03/15/2007 | CA2662798A1 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 03/15/2007 | CA2621767A1 Prion-specific peptoid reagents |
| 03/15/2007 | CA2621360A1 Ring-closing metathesis process for the preparation of macrocyclic peptides |
| 03/14/2007 | EP1761783A2 Identification of compounds modifying a cellular response |
| 03/14/2007 | CN1930293A Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 03/14/2007 | CN1930183A Biologically active peptides comprising phenylalanyl-glutamate (FE) and phenylalanyl-glutamyl-glutamate (FEE) |
| 03/14/2007 | CN1930182A Antithrombotic compound |
| 03/14/2007 | CN1304424C Compounds with growth hormone releasing properties |
| 03/14/2007 | CN1304417C Intermediates for LHRH antagonist synthesis, process for their production, and process for LHRH antagonist production |
| 03/14/2007 | CN1304416C Heterocyclic tripeptides as hepatitis C inhibitors |
| 03/14/2007 | CN1304415C Pyrane derivatives as both ACE- and NEP- inhibitors |
| 03/14/2007 | CN1304362C Prepn process of metal-amino acid chelate |
| 03/13/2007 | US7189864 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
| 03/13/2007 | US7189857 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 03/13/2007 | US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins |
| 03/13/2007 | US7189801 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189701 Tetrapeptide stimulating functional activity of neurons pharmacological agent based thereon and method of use thereof |
| 03/13/2007 | US7189692 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 03/13/2007 | US7189691 Methods and compositions for treating leukemia |
| 03/13/2007 | US7189689 Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders |
| 03/13/2007 | CA2373128C Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/08/2007 | WO2007027628A1 Dmt-derivative compounds and related compositions and methods of use |
| 03/08/2007 | WO2007025366A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |